 Inclusion Criteria run-in period: T1-T4, metastatic M1 prostate cancer T1-T4, non-metastatic M0 prostate cancer with PSA 60 ngmL T3-T4, non-metastatic M0 prostate cancer with PSA 20ngmL T1-T4, N prostate cancer WHO performance status 0-2 Written informed consent 